Lindley Avina MD in Pahrump, Nevada

Medical School: Medical College Of Pennsylvania
Graduation Year: 1993
The Primary Medical Specialty for Lindley Avina MD is listed as: Cardiovascular Disease (cardiology)
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 31
PAC (PECOS ID)#: 5991725509
NPI #: 1649360447
NPI Created On: 10/13/2006
NPI Last Updated Listed as: 10/25/2022
Primary Taxonomy Code: 207RC0000X
License Number:
8901
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Humana
• Health Plan of Nevada, Inc.
• Medicare

They are listed as accepting new patients.

Languages spoken by staff include: English, Spanish.

Services and Procedures include:

1. External ekg recording for more than 48 hours up to 21 days
2. Review and interpretation of external ekg recording for more than 48 hours up to 21 days
3. Nuclear medicine study of vessels of heart using drugs or exercise multiple studies
4. Blood test, clotting time
5. Routine ekg using at least 12 leads including interpretation and report
6. Exercise or drug-induced heart and blood vessel stress test with ekg monitoring, physician supervision, interpretation, and report
7. Ultrasound examination of heart including color-depicted blood flow rate, direction, and valve function
8. Doppler ultrasound study of heart blood flow, valves, and chambers
9. Ultrasound examination of the heart performed during rest, exercise, and/or drug-induced stress with interpretation and report
10. Injection of x-ray contrast material for ultrasound examination of the heart
11. Ultrasound scanning of blood flow (outside the brain) on both sides of head and neck
12. New patient office or other outpatient visit, typically 45 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Physician telephone patient service, 11-20 minutes of medical discussion
16. Technetium tc-99m sestamibi, diagnostic, per study dose
17. Injection, regadenoson, 0.1 mg
18. Injection, perflutren lipid microspheres, per ml